| [1] |
Yan H H N, Siu H C, Law S, et al. A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening [J]. Cell Stem Cell, 2018, 23(6): 882-97 e11.
|
| [2] |
Broutier L, Mastrogiovanni G, Verstegen M M, et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening [J]. Nat Med, 2017, 23(12): 1424-35.
|
| [3] |
Tiriac H, Belleau P, Engle D D, et al. Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer [J]. Cancer Discov, 2018, 8(9): 1112-29.
|
| [4] |
Tam K, Schoppy D W, Shin J H, et al. Assessing the Impact of Targeting CEACAM1 in Head and Neck Squamous Cell Carcinoma [J]. Otolaryngol Head Neck Surg, 2018, 159(1): 76-84.
|
| [5] |
Yoon A J, Santella R M, Wang S, et al. MicroRNA-Based Cancer Mortality Risk Scoring System and hTERT Expression in Early-Stage Oral Squamous Cell Carcinoma [J]. J Oncol, 2021, 2021: 8292453.
|
| [6] |
Algazi A P, Grandis J R. Head and neck cancer in 2016: A watershed year for improvements in treatment? [J]. Nat Rev Clin Oncol, 2017, 14(2): 76-8.
|
| [7] |
Ju W T, Ma H L, Zhao T C, et al. Stathmin guides personalized therapy in oral squamous cell carcinoma [J]. Cancer Sci, 2020, 111(4): 1303-13.
|
| [8] |
Chitturi Suryaprakash R T, Kujan O, Shearston K, et al. Three-Dimensional Cell Culture Models to Investigate Oral Carcinogenesis: A Scoping Review [J]. Int J Mol Sci, 2020, 21(24).
|
| [9] |
Horvath P, Aulner N, Bickle M, et al. Screening out irrelevant cell-based models of disease [J]. Nat Rev Drug Discov, 2016, 15(11): 751-69.
|
| [10] |
Bissell M J, Radisky D. Putting tumours in context [J]. Nat Rev Cancer, 2001, 1(1): 46-54.
|
| [11] |
Jensen C, Teng Y. Is It Time to Start Transitioning From 2D to 3D Cell Culture? [J]. Front Mol Biosci, 2020, 7: 33.
|
| [12] |
Byrne A T, Alferez D G, Amant F, et al. Interrogating open issues in cancer precision medicine with patient-derived xenografts [J]. Nat Rev Cancer, 2017, 17(4): 254-68.
|
| [13] |
Ben-David U, Ha G, Tseng Y Y, et al. Patient-derived xenografts undergo mouse-specific tumor evolution [J]. Nat Genet, 2017, 49(11): 1567-75.
|
| [14] |
Driehuis E, Kretzschmar K, Clevers H. Establishment of patient-derived cancer organoids for drug-screening applications [J]. Nat Protoc, 2020, 15(10): 3380-409.
|
| [15] |
Tanaka N, Osman A A, Takahashi Y, et al. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity [J]. Oral Oncol, 2018, 87: 49-57.
|
| [16] |
Karakasheva T A, Kijima T, Shimonosono M, et al. Generation and Characterization of Patient-Derived Head and Neck, Oral, and Esophageal Cancer Organoids [J]. Curr Protoc Stem Cell Biol, 2020, 53(1): e109.
|
| [17] |
Lin K C, Ting L L, Chang C L, et al. Ex Vivo Expanded Circulating Tumor Cells for Clinical Anti-Cancer Drug Prediction in Patients with Head and Neck Cancer [J]. Cancers (Basel), 2021, 13(23).
|
| [18] |
Zhao H, Jiang E, Shang Z. 3D Co-culture of Cancer-Associated Fibroblast with Oral Cancer Organoids [J]. J Dent Res, 2021, 100(2): 201-8.
|
| [19] |
Chen X, Li R, Zhao H, et al. Phenotype transition of fibroblasts incorporated into patient-derived oral carcinoma organoids [J]. Oral Dis, 2021.
|
| [20] |
Neal J T, Li X, Zhu J, et al. Organoid Modeling of the Tumor Immune Microenvironment [J]. Cell, 2018, 175(7): 1972-88 e16.
|
| [21] |
Dijkstra K K, Cattaneo C M, Weeber F, et al. Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids [J]. Cell, 2018, 174(6): 1586-98 e12.
|
| [22] |
Johansson E, Ueno H. Characterization of normal and cancer stem-like cell populations in murine lingual epithelial organoids using single-cell RNA sequencing [J]. Sci Rep, 2021, 11(1): 22329.
|
| [23] |
Driehuis E, Kolders S, Spelier S, et al. Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy [J]. Cancer Discov, 2019, 9(7): 852-71.
|
| [24] |
Khalil B D, Sanchez R, Rahman T, et al. An NR2F1-specific agonist suppresses metastasis by inducing cancer cell dormancy [J]. J Exp Med, 2022, 219(1).
|
| [25] |
Farnebo L, Shahangian A, Lee Y, et al. Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma [J]. Oncotarget, 2015, 6(12): 9897-907.
|
| [26] |
Hill S J, D'andrea A D. Predictive Potential of Head and Neck Squamous Cell Carcinoma Organoids [J]. Cancer Discov, 2019, 9(7): 828-30.
|
